Tenon Medical, Inc.
TNON
$1.17
$0.021.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -4.70% | -6.04% | 21.27% | 66.05% | 191.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.70% | -6.04% | 21.27% | 66.05% | 191.70% |
| Cost of Revenue | 67.47% | 14.67% | -21.49% | -48.13% | -48.55% |
| Gross Profit | -36.85% | -21.87% | 142.27% | 1,100.00% | 370.05% |
| SG&A Expenses | -1.73% | -6.30% | 0.53% | -17.43% | -56.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.15% | -5.09% | -5.77% | -20.57% | -51.87% |
| Operating Income | -1.02% | 4.83% | 10.41% | 28.24% | 60.38% |
| Income Before Tax | 1.50% | 4.44% | 10.71% | 25.96% | 60.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1.50% | 4.44% | 10.71% | 25.96% | 60.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.50% | 4.44% | 10.71% | 25.96% | 60.35% |
| EBIT | -1.02% | 4.83% | 10.41% | 28.24% | 60.38% |
| EBITDA | -0.26% | 6.57% | 11.76% | 29.93% | 61.43% |
| EPS Basic | 90.08% | 68.95% | 68.92% | 70.83% | 82.43% |
| Normalized Basic EPS | 90.08% | 68.95% | 68.92% | 70.83% | 82.43% |
| EPS Diluted | 90.08% | 68.95% | 68.92% | 70.83% | 82.43% |
| Normalized Diluted EPS | 90.08% | 68.95% | 68.92% | 70.83% | 82.43% |
| Average Basic Shares Outstanding | 893.38% | 207.72% | 187.31% | 153.81% | 125.62% |
| Average Diluted Shares Outstanding | 893.38% | 207.72% | 187.31% | 153.81% | 125.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |